Oh my !! CDFT is doing so good !!
Other than the info
Oh my !! CDFT is doing so good !!
Other than the info that I am looking at , just reading the post on liehub by the JSO tells everyone that isn't an idiot basher that CDFT is the real deal !! BAM !! FACT !!
Can you believe the idiot JSO still discussing the REAL bonds ?!?!?
They are of no consequence anymore yet this is all the JSO has !! LMAO !!
Poor little JSO idiots !! HAHAHA !!!!!
Citadel EFT Inc (CDFT) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking New Ground in Hearing Conservation This time, we're looking at SHOEBOX PureTest snagging the 2026 Hearing Technology Innovator Award. It marks yet another feather in their cap, standing tall in the Equipment, Audiometry category. You know, for those of us knee-deep in the stock game—and I mean neck-deep in financial stakes—spotting a company thriving through...
Continue Reading
What’s Orangetheory Up To Now? Ah, fitness gadgets, where everyone’s seemingly got a scheme brewing. This time it's Orangetheory (OTF), turning your Apple Watch into your new best gym buddy. October 22, 2026, marks the launch of OTconnect for Apple Watch, offering a slick way for enthusiasts to tune into their own sweat metrics. If you’re already an Apple Watch...
Continue Reading
A Digital Lifeline for Nursing Students Nursing students are buried in responsibilities: lectures, clinical rotations, and sometimes even a job to fund the whole marathon. And just when they think they’ve got it handled, boom, a mountain of exams rises up in front of them. AceMyNursingExams gets this, rolling out an online exam prep platform to keep these future...
Continue Reading
Real Estate Clash: MLS vs. Compass Imagine flipping on the TV to see a legal showdown brewing in the real estate world — you've got six heavy-hitter MLSs facing off against Compass, Inc. Yeah, we're talking a legal slugfest here, folks, as these MLSs rally to keep the playing field level for over 120,000 agents across the country. They're not messing around, bringing a...
Continue Reading
A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...
Continue Reading
Wake Up Call for College Athletics Here's a heads-up—college sports aren't just about cheering fans and game-day jerseys anymore. It's high time universities start thinking of athletics as businesses, blending the thrill of game day with the realities of financial statements. Michael Schreiber rang this bell loud and clear on the 'Disruption Interruption' podcast,...
Continue Reading
Bringing Financial Flexibility to Venue Employees Oak View Group (OVG) has taken a bold step toward enhancing the financial lives of its workforce. They’ve teamed up with Payactiv, the trailblazer in Earned Wage Access (EWA), to deliver a more flexible way for their employees to access funds they've already earned. This move stretches across more than 40 locations...
Continue Reading
Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...
Continue Reading
Asking the World to See LGS Life throws curveballs, but Lennox-Gastaut Syndrome (LGS) comes barreling down like a freight train in the quiet. It's a rare form of epilepsy that sows chaos in young lives with relentless seizures, leaving families in a fog of uncertainty and heartbreak for years. On International LGS Awareness Day™, November 1, families and advocates are...
Continue Reading
Ping An Good Doctor's Noteworthy Financial Uptick Stop me if you've heard this one: a hefty hike in numbers that make investors straighten up a bit. Ping An Good Doctor did just that, reporting a 35% spark in net profit as the books closed up till September 2026. In a landscape where many health-tech firms merely tread water, these guys rode a wave of RMB 0.25 billion in...
Continue Reading
Top 5 Most Recently Viewed Articles
Nasuni Empowers Major Brands for Holiday Success Household brands are continually enhancing their competitiveness, driving customer growth, and boosting productivity with Nasuni's cutting-edge hybrid cloud solutions. As the holiday season approaches, the demands on retailers increase significantly. Nasuni, an enterprise data platform known for its robust capabilities in...
Continue Reading
JDE Peet’s Employee Incentive Plans: Recent Grants and Transfers JDE Peet’s N.V. (EURONEXT: JDEP) has made significant strides in its approach to employee incentives, emphasizing its dedication to valuing its workforce. In a recent announcement, the company outlined its actions regarding share grants as part of its ongoing employee incentive plans. These initiatives...
Continue Reading
Liongard Appoints Brook Lee as VP to Enhance MSP Engagement Liongard, a leading name in Attack Surface Management catering to Managed Service Providers (MSPs) and IT Service Providers, is excited to announce the appointment of Brook Lee as its new Vice President of Community and Channel. With more than 15 years of experience within the MSP industry, Brook brings a wealth...
Continue Reading
Honoring Dr. Rachel L. Ivory for Her Educational Contributions Featured prominently as a Pinnacle Professional Member, Dr. Rachel L. Ivory stands out for her substantial contributions to the fields of education and literature. Her dedication has led her to be recognized by many for her impactful work, especially in leadership training, publishing, and community...
Continue Reading
Results Revealed: A Game Changer in Cholangiocarcinoma Treatment Zenocutuzumab is stirring the pot in cancer treatment with some potentially ground-breaking results recently unveiled. Partner Therapeutics, a biotech player with skin in the oncology game, has revealed results from the eNRGy trial. These findings have not only turned heads but also led to U.S. FDA approval...
Continue Reading